Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

88 results
Display

Association Between Body Mass Index and Functional Dyspepsia in Young Japanese People

Yamamoto Y, Furukawa S, Watanabe J, Kato A, Kusumoto K, Takeshita E, Ikeda Y, Yamamoto N, Kohara K, Saeki Y, Hiasa Y

  • KMID: 2528042
  • J Neurogastroenterol Motil.
  • 2022 Apr;28(2):276-282.
  • doi: 10.5056/jnm21076
Background/Aims Evidence regarding the association between body mass index (BMI) and functional dyspepsia (FD) in the Asian population is limited. Further, no study has evaluated this issue in young people in Asian...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Duodenal Microbiome and Its Clinical Implications in Functional Dyspepsia

Kim SH

Functional dyspepsia is one of the most common functional gastrointestinal disorders with chronic bothersome epigastric pain or postprandial fullness without a definite organic cause. Despite its high clinical burden, the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Autophagy and Digestive Disorders: Advances in Understanding and Therapeutic Approaches

Thein W, Po WW, Choi WS, Sohn UD

The gastrointestinal (GI) tract is a series of hollow organs that is responsible for the digestion and absorption of ingested foods and the excretion of waste. Any changes in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Motilitone toxicity in a dog

Kim YH, Ahn JO, Jeong Y, Kang MS, Choi JH, Chung JY

A three-month-old, intact male Maltese dog was presented to the hospital with lethargy after taking human medication, Motilitone. Physical examination, including a neurological examination, revealed no remarkable findings, but cholinergic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multicenter, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of a Controlled-release, Once-daily UIC201609/UIC201610 Combination Therapy for Functional Dyspepsia: Preliminary Study

Lee JW, Youn YH, Choi SC, Lee KJ, Kim N

Background/Aims: Functional dyspepsia is a disease involving a range of upper gastrointestinal symptoms derived from various pathophysiologies. Tablets containing a combination of rabeprazole and controlled-release (CR) mosapride were recently developed. To...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial

Yoon H, Lee DH, Lee YH, Jeong JC, Lee ST, Choi MG, Jeon SW, Shim KN, Baik GH, Kim JG, Moon JS, Sung IK, Lee SK, Rhee PL, Jung HY, Lee BE, Kim HS, Kim SG, Lee KM, Seong JK, Jang JS, Park JJ

BACKGROUND/AIMS: To evaluate the efficacy and safety of a controlled release, once-daily formulation of mosapride (UI05MSP015CT) in patients with functional dyspepsia (FD). METHODS: Patients with FD were randomly assigned (1:1) to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Randomized, Double-blind, Placebo-controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Artemisia and Green Tea Extract SD1003F in Volunteers with Helicobacter pylori-associated Gastric Discomfort

Kwon SO, Kwak DY, Hong SP, Kim WH, Park JM, Han YM, Kang Y, Kang EA, Jo S, Hahm KB

BACKGROUND/AIMS: A previous study showed that dietary intervention with Artemisia and green tea extracts, i.e., SD1003F, relieved Helicobacter pylori-associated chronic atrophic gastritis in a mouse model. We continue the research...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is Helicobacter pylori Associated Functional Dyspepsia Correlated With Dysbiosis?

Kim YJ, Chung WC, Kim BW, Kim SS, Kim JI, Kim NJ, Yoo J, Kim SH

  • KMID: 2395418
  • J Neurogastroenterol Motil.
  • 2017 Oct;23(4):504-516.
  • doi: 10.5056/jnm17066
BACKGROUND/AIMS: To assess the long-term effect of Helicobacter pylori eradication on symptomatic improvement according to the type of antibiotic and the duration of treatment in H. pylori-associated functional dyspepsia. METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Understanding the Rome IV: Gastroduodenal Disorders

Jung KW

Gastroduodenal symptoms are very common in the general population. The symptoms are classified into four categories according to the newly revised Rome IV criteria: functional dyspepsia (including postprandial discomfort and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Functional Dyspepsia: Advances in Diagnosis and Therapy

Talley NJ

Functional dyspepsia (FD) is a common but under-recognized syndrome comprising bothersome recurrent postprandial fullness, early satiety, or epigastric pain/burning. Epidemiologically, there are two clinically distinct FD syndromes (although these often...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Status of Translational Research on Functional Dyspepsia

Park JH, Kim JW, Park JK, Shin CM, Jung KW

Functional dyspepsia (FD) has a diverse pathophysiology and treatment is difficult. Translational research to understand its pathophysiology is underway. Hormonal factors, including ghrelin, seem promising, offering an understanding of appetite...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Study of Effects of Psychosocial Factors and Quality of Life on Functional Dyspepsia in Firefighters

Jang SH, Ryu HS, Choi SC, Lee HJ, Lee SY

OBJECTIVES: The purpose of this study was to investigate the characteristics of psychosocial factors related to functional dyspepsia(FD) and their effects on quality of life(QOL) in firefighters. METHODS: This study examined...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnosis and treatment of functional dyspepsia

Shin CM, Huh KC

Functional dyspepsia is defined as the presence of the symptoms that originate from the gastroduodenal area, without evidence of any organic, systemic, or metabolic disease that could explain these symptoms....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diet and Nutritional Management in Functional Gastrointestinal Disorder: Functional Dyspepsia

Shin CM

Diet play an important role in triggering symptoms in patients with functional dyspepsia. The pathophysiology of functional dyspepsia is characterized by impaired gastric accommodation and visceral hypersensitivity, and patterns of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia

Choi MG, Rhee PL, Park H, Lee OY, Lee KJ, Choi SC, Seol SY, Chun HJ, Rew JS, Lee DH, Song GA, Jung HY, Jeong HY, Sung IK, Lee JS, Lee ST, Kim SK, Shin YW

  • KMID: 2433481
  • J Neurogastroenterol Motil.
  • 2015 Jul;21(3):414-422.
  • doi: 10.5056/jnm14117
BACKGROUND/AIMS: Therapies of functional dyspepsia (FD) are limited. DA-9701 is a novel prokinetic agent formulated with Pharbitis semen and Corydalis Tuber. We aimed to assess the efficacy of DA-9701 compared...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Pharmacological Effects of Benachio-F(R) on Rat Gastrointestinal Functions

Poudel BK, Yu JY, Kwon YS, Park HG, Son M, Jun JH, Kim JA, Kim JO

Functional dyspepsia (FD) is a prevalent idiopathic upper gastrointestinal (GI) disorder characterized by diverse symptomatology including epigastric pain or discomfort, postprandial fullness, and early satiety. Although its pathophysiological mechanisms have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of New Prokinetic Agent Benachio Q Solution(R) in Patients with Postprandial Distress Syndrome Subtype in Functional Dyspepsia: A Single-center, Randomized, Double-blind, Placebo-controlled Pilot Study

Shim YK, Lee JY, Kim N, Park YH, Yoon H, Shin CM, Park YS, Lee DH

BACKGROUND/AIMS: Functional dyspepsia (FD) is a gastrointestinal disorder in which the patient suffers from chronic abdominal symptoms despite the absence of organic disease. Benachio Q solution (soln.)(R) is a new...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medical treatment of functional dyspepsia

Kim SE

Functional dyspepsia (FD) is a condition in which upper abdominal symptoms, such as epigastralgia, postprandial discomfort, and bloating, occur in the absence of any organic or metabolic disease that could...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of Eating Attitude and Impairment of Physical Quality of Life Between Tertiary Clinic and Primary Clinic Functional Dyspepsia Outpatients in Japan

Shimpuku M, Futagami S, Tajima N, Yamawaki H, Maruki Y, Kodaka Y, Nagoya H, Gudis K, Kawagoe T, Sakamoto C

  • KMID: 2381215
  • J Neurogastroenterol Motil.
  • 2014 Oct;20(4):506-515.
  • doi: 10.5056/jnm14015
BACKGROUND/AIMS: There is no available data on factors associated with healthcare-seeking behavior for functional dyspepsia (FD) symptoms at either tertiary or primary clinics in Japan. Therefore, we aimed to compare...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of GC7101, a Novel Prokinetic Agent on Gastric Motor Function: Ex Vivo Study

Jung DH, Choi EJ, Jeon HH, Lee YH, Park H

  • KMID: 2381210
  • J Neurogastroenterol Motil.
  • 2014 Oct;20(4):469-474.
  • doi: 10.5056/jnm14010
BACKGROUND/AIMS: GC7101, an extract of Lonicera Flos, is a novel developing drug for reflux esophagitis and functional dyspepsia. However, the drug's exact pharmacological mechanism of action remains unclear. This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr